MicroVision (MVIS) Financials

$1.12 -0.02 (-1.33%)

As of 12:30 PM Eastern

Annual Income Statements for MicroVision

This table shows MicroVision's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-53	-83	-97
Consolidated Net Income / (Loss)	-53	-83	-97
Net Income / (Loss) Continuing Operations	-53	-83	-97
Total Pre-Tax Income	-53	-82	-96
Total Operating Income	-54	-89	-86
Total Gross Profit	0.56	4.49	-2.83
Total Revenue	0.66	7.26	4.70
Operating Revenue	0.66	7.26	4.70
Total Cost of Revenue	0.10	2.77	7.53
Operating Cost of Revenue	0.10	2.77	7.53
Total Operating Expenses	54	93	83
Selling, General & Admin Expense	24	37	29
Research & Development Expense	30	57	49
Impairment Charge	0.00	0.00	4.18
Other Special Charges / (Income)	0.00	-0.03	0.14
Total Other Income / (Expense), net	0.80	7.18	-11
Interest Expense	0.06	0.08	4.46
Other Income / (Expense), net	0.86	7.26	-6.43
Income Tax Expense	0.00	1.15	0.51
Weighted Average Basic Shares Outstanding	165.96M	182.80M	209.51M
Weighted Average Diluted Shares Outstanding	165.96M	182.80M	209.51M
Weighted Average Basic & Diluted Shares Outstanding	175.82M	195.27M	245.00M

This table shows MicroVision's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-13	-13	-19	-21	-23	-20	-26	-24	-16	-31
Consolidated Net Income / (Loss)	-13	-13	-19	-21	-23	-20	-26	-24	-16	-31
Net Income / (Loss) Continuing Operations	-13	-13	-19	-21	-23	-20	-26	-24	-16	-31
Total Pre-Tax Income	-13	-14	-19	-20	-23	-19	-26	-24	-15	-31
Total Operating Income	-13	-14	-21	-24	-24	-20	-27	-25	-16	-18
Total Gross Profit	-0.05	-0.03	0.24	-0.37	0.42	4.20	-0.32	0.35	-0.39	-2.47
Total Revenue	0.00	-	0.78	0.33	1.05	5.10	0.96	1.90	0.19	1.65
Operating Revenue	0.00	-	0.78	0.33	1.05	5.10	0.96	1.90	0.19	1.65
Total Cost of Revenue	0.05	0.03	0.54	0.70	0.63	0.90	1.28	1.55	0.58	4.12
Operating Cost of Revenue	0.05	0.03	0.54	0.70	0.63	0.90	1.28	1.55	0.58	4.12
Total Operating Expenses	13	14	21	24	24	24	26	25	15	16
Selling, General & Admin Expense	5.52	6.38	8.74	9.69	8.74	9.52	9.08	7.75	6.60	5.92
Research & Development Expense	7.54	7.59	13	14	16	15	17	14	8.74	8.76
Total Other Income / (Expense), net	0.25	0.48	2.35	3.57	0.64	0.63	0.63	0.79	0.30	-13
Other Income / (Expense), net	0.25	-	2.35	3.57	0.64	0.71	0.63	0.79	0.30	-8.15
Income Tax Expense	0.00	-	0.18	0.28	0.21	0.48	0.23	0.08	0.11	0.08
Weighted Average Basic Shares Outstanding	165.69M	165.96M	174.70M	177.30M	188.31M	182.80M	196.75M	208.67M	213.00M	209.51M
Weighted Average Diluted Shares Outstanding	165.69M	165.96M	174.70M	177.30M	188.31M	182.80M	196.75M	208.67M	213.00M	209.51M
Weighted Average Basic & Diluted Shares Outstanding	166.04M	175.82M	176.52M	187.78M	189.99M	195.27M	206.66M	212.75M	219.02M	245.00M

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-62	27	6.86
Net Cash From Operating Activities	-38	-67	-69
Net Cash From Continuing Operating Activities	-38	-67	-69
Net Income / (Loss) Continuing Operations	-53	-83	-97
Consolidated Net Income / (Loss)	-53	-83	-97
Depreciation Expense	2.25	7.86	6.92
Amortization Expense	0.00	0.00	4.38
Non-Cash Adjustments To Reconcile Net Income	16	13	26
Changes in Operating Assets and Liabilities, net	-2.81	-5.36	-9.15
Net Cash From Investing Activities	-38	22	2.67
Net Cash From Continuing Investing Activities	-38	22	2.67
Purchase of Property, Plant & Equipment	-4.36	-1.94	-0.37
Acquisitions	-4.13	-11	-6.30
Purchase of Investments	-90	-42	-26
Sale and/or Maturity of Investments	61	77	35
Net Cash From Financing Activities	14	72	73
Net Cash From Continuing Financing Activities	14	72	73
Repayment of Debt	-0.39	0.00	0.00
Issuance of Debt	0.00	0.00	38
Issuance of Common Equity	14	72	35
Other Financing Activities, net	0.70	0.15	0.06
Effect of Exchange Rate Changes	0.00	0.27	-0.17

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-15	-1.44	5.46	39	-13	-4.20	-3.05	-18	-10	38
Net Cash From Operating Activities	-9.01	-8.40	-13	-17	-20	-17	-21	-19	-14	-15
Net Cash From Continuing Operating Activities	-9.00	-8.40	-13	-17	-20	-17	-21	-19	-14	-15
Net Income / (Loss) Continuing Operations	-13	-13	-19	-21	-23	-20	-26	-24	-16	-31
Consolidated Net Income / (Loss)	-13	-13	-19	-21	-23	-20	-26	-24	-16	-31
Depreciation Expense	0.52	0.82	2.52	1.63	2.14	1.58	1.80	1.77	1.68	1.67
Non-Cash Adjustments To Reconcile Net Income	4.15	3.29	0.68	3.78	4.40	4.39	3.48	6.55	2.26	14
Changes in Operating Assets and Liabilities, net	-0.82	0.96	2.34	-1.44	-3.45	-2.81	0.28	-3.03	-2.51	-3.90
Net Cash From Investing Activities	-6.28	-7.03	6.25	12	2.70	0.44	-3.28	-4.13	3.58	6.50
Net Cash From Continuing Investing Activities	-6.28	-7.03	6.25	12	2.70	0.44	-3.28	-4.13	3.58	6.50
Purchase of Property, Plant & Equipment	-0.89	-2.34	-0.62	-0.87	-0.50	0.05	-0.11	-0.17	0.01	-0.10
Purchase of Investments	-26	-26	-3.90	-13	-9.80	-15	-7.81	-16	-2.08	-0.50
Sale and/or Maturity of Investments	20	26	22	27	13	15	7.90	15	5.66	7.10
Net Cash From Financing Activities	0.31	14	13	43	4.74	12	21	5.15	-0.02	47
Net Cash From Continuing Financing Activities	0.31	14	13	43	4.74	12	21	5.15	-0.02	47
Issuance of Common Equity	-	14	13	43	4.74	12	21	5.15	-0.02	8.66
Effect of Exchange Rate Changes	-	-	0.00	-	-	0.27	-0.03	0.06	0.11	-0.30

This table presents MicroVision's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	115	130	121
Total Current Assets	91	87	82
Cash & Equivalents	21	45	54
Restricted Cash	0.00	3.26	0.26
Short-Term Investments	62	29	20
Accounts Receivable	0.00	0.95	0.93
Inventories, net	1.86	3.87	2.29
Other Current Assets	6.44	4.89	4.29
Plant, Property, & Equipment, net	6.83	9.03	7.06
Total Noncurrent Assets	17	34	32
Intangible Assets	0.08	17	11
Other Noncurrent Operating Assets	17	17	21
Total Liabilities & Shareholders' Equity	115	130	121
Total Liabilities	25	34	72
Total Current Liabilities	11	21	46
Short-Term Debt	0.00	0.00	24
Accounts Payable	2.06	2.27	1.13
Accrued Expenses	2.06	15	2.54
Other Current Liabilities	2.71	3.29	18
Total Noncurrent Liabilities	14	13	26
Long-Term Debt	-	0.00	8.75
Capital Lease Obligations	-	13	16
Other Noncurrent Operating Liabilities	14	0.61	1.73
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	90	96	49
Total Preferred & Common Equity	90	96	49
Preferred Stock	0.00	0.00	0.00
Total Common Equity	90	96	49
Common Stock	772	861	911
Retained Earnings	-683	-765	-862
Accumulated Other Comprehensive Income / (Loss)	-0.13	0.21	0.00

This table presents MicroVision's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	109	123	149	136	124	103	88
Total Current Assets	88	77	103	91	82	67	53
Cash & Equivalents	22	23	62	49	44	27	17
Restricted Cash	-	3.26	3.26	3.26	0.07	0.07	0.27
Short-Term Investments	61	45	32	29	29	30	27
Accounts Receivable	-	0.51	0.82	0.74	1.12	1.97	0.23
Inventories, net	1.76	3.12	2.93	3.62	3.74	4.20	4.49
Other Current Assets	2.83	2.37	2.33	5.77	4.30	3.65	4.86
Plant, Property, & Equipment, net	4.55	10	9.95	9.46	8.55	8.13	7.67
Total Noncurrent Assets	17	36	35	35	33	29	28
Intangible Assets	0.09	19	18	18	17	13	13
Other Noncurrent Operating Assets	17	17	17	17	17	16	15
Total Liabilities & Shareholders' Equity	109	123	149	136	124	103	88
Total Liabilities	24	37	36	38	30	25	22
Total Current Liabilities	9.96	22	23	24	18	13	11
Short-Term Debt	0.00	-	8.48	8.55	5.14	0.00	0.00
Accounts Payable	1.52	3.63	1.89	2.29	2.16	1.45	1.49
Accrued Expenses	1.59	10	6.60	7.20	9.97	8.89	5.89
Current Deferred Revenue	4.60	-	5.73	4.96	0.21	0.17	0.18
Other Current Liabilities	2.25	8.11	0.00	1.06	0.27	2.14	3.05
Total Noncurrent Liabilities	14	15	13	14	13	12	12
Other Noncurrent Operating Liabilities	14	14	13	14	13	12	12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	86	87	113	98	94	79	66
Total Preferred & Common Equity	86	87	113	98	94	79	66
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	86	87	113	98	94	79	66
Common Stock	755	788	835	844	885	894	897
Retained Earnings	-669	-702	-722	-746	-792	-816	-831
Accumulated Other Comprehensive Income / (Loss)	-0.19	0.06	-0.01	0.05	0.16	0.10	0.34

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-73.44%	993.22%	-35.31%
EBITDA Growth	-19.69%	-45.23%	-9.35%
EBIT Growth	-20.82%	-53.91%	-12.66%
NOPAT Growth	-22.84%	-64.92%	3.78%
Net Income Growth	-22.90%	-56.04%	-16.99%
EPS Growth	-18.52%	-40.63%	0.00%
Operating Cash Flow Growth	-29.30%	-76.46%	-2.16%
Free Cash Flow Firm Growth	-35.15%	-84.57%	40.98%
Invested Capital Growth	420.36%	347.63%	-27.69%
Revenue Q/Q Growth	-45.62%	236.38%	-42.36%
EBITDA Q/Q Growth	-0.23%	2.79%	-3.70%
EBIT Q/Q Growth	-0.98%	1.65%	-8.69%
NOPAT Q/Q Growth	-2.62%	-7.10%	1.63%
Net Income Q/Q Growth	-1.63%	-8.18%	-13.35%
EPS Q/Q Growth	0.00%	-4.65%	0.00%
Operating Cash Flow Q/Q Growth	-0.65%	-13.88%	2.17%
Free Cash Flow Firm Q/Q Growth	-13.94%	-6.69%	11.41%
Invested Capital Q/Q Growth	196.83%	23.42%	1.69%
Profitability Metrics	-	-	-
Gross Margin	84.94%	61.81%	-60.35%
EBITDA Margin	-7,648.04%	-1,016.01%	-1,717.40%
Operating Margin	-8,115.96%	-1,224.34%	-1,821.10%
EBIT Margin	-7,986.30%	-1,124.34%	-1,958.07%
Profit (Net Income) Margin	-7,995.63%	-1,141.23%	-2,063.78%
Tax Burden Percent	100.00%	101.40%	100.53%
Interest Burden Percent	100.12%	100.10%	104.85%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1,559.77%	-323.11%	-220.74%
ROIC Less NNEP Spread (ROIC-NNEP)	-1,544.22%	-295.05%	-138.71%
Return on Net Nonoperating Assets (RNNOA)	1,507.33%	233.81%	86.67%
Return on Equity (ROE)	-52.44%	-89.30%	-134.07%
Cash Return on Invested Capital (CROIC)	-667.66%	-450.06%	-188.60%
Operating Return on Assets (OROA)	-43.25%	-66.73%	-73.33%
Return on Assets (ROA)	-43.30%	-67.73%	-77.29%
Return on Common Equity (ROCE)	-52.44%	-89.30%	-134.07%
Return on Equity Simple (ROE_SIMPLE)	-59.16%	-86.47%	-198.72%
Net Operating Profit after Tax (NOPAT)	-38	-62	-60
NOPAT Margin	-5,681.17%	-857.04%	-1,274.77%
Net Nonoperating Expense Percent (NNEP)	-15.55%	-28.06%	-82.03%
Return On Investment Capital (ROIC_SIMPLE)	-42.04%	-57.33%	-61.26%
Cost of Revenue to Revenue	15.06%	38.19%	160.35%
SG&A Expenses to Revenue	3,620.63%	505.43%	624.91%
R&D to Revenue	4,580.27%	781.20%	1,043.76%
Operating Expenses to Revenue	8,200.90%	1,286.16%	1,760.75%
Earnings before Interest and Taxes (EBIT)	-53	-82	-92
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-51	-74	-81
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	4.35	5.28	5.88
Price to Tangible Book Value (P/TBV)	4.35	6.43	7.59
Price to Revenue (P/Rev)	587.62	69.62	61.10
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	43.73	14.01	11.46
Enterprise Value to Revenue (EV/Rev)	463.06	60.76	55.56
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.13	1.00
Long-Term Debt to Equity	0.00	0.13	0.51
Financial Leverage	-0.98	-0.79	-0.62
Leverage Ratio	1.21	1.32	1.73
Compound Leverage Factor	1.21	1.32	1.82
Debt to Total Capital	0.00%	11.72%	50.10%
Short-Term Debt to Total Capital	0.00%	0.00%	24.81%
Long-Term Debt to Total Capital	0.00%	11.72%	25.28%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	88.28%	49.90%
Debt to EBITDA	0.00	-0.17	-0.61
Net Debt to EBITDA	0.00	0.87	0.32
Long-Term Debt to EBITDA	0.00	-0.17	-0.31
Debt to NOPAT	0.00	-0.20	-0.82
Net Debt to NOPAT	0.00	1.03	0.43
Long-Term Debt to NOPAT	0.00	-0.20	-0.41
Altman Z-Score	0.28	-0.71	-9.69
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	7.97	4.23	1.79
Quick Ratio	7.24	3.64	1.65
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-47	-87	-51
Operating Cash Flow to CapEx	-872.20%	-3,467.18%	-18,326.20%
Free Cash Flow to Firm to Interest Expense	-757.26	-1,083.22	-11.48
Operating Cash Flow to Interest Expense	-613.21	-838.63	-15.38
Operating Cash Flow Less CapEx to Interest Expense	-683.52	-862.81	-15.46
Efficiency Ratios	-	-	-
Asset Turnover	0.01	0.06	0.04
Accounts Receivable Turnover	0.00	0.00	5.01
Inventory Turnover	0.05	0.97	2.44
Fixed Asset Turnover	0.13	0.92	0.58
Accounts Payable Turnover	0.04	1.28	4.43
Days Sales Outstanding (DSO)	0.00	0.00	72.87
Days Inventory Outstanding (DIO)	6,644.83	377.57	149.49
Days Payable Outstanding (DPO)	10,302.13	285.21	82.48
Cash Conversion Cycle (CCC)	-3,657.30	92.37	139.88
Capital & Investment Metrics	-	-	-
Invested Capital	7.03	31	23
Invested Capital Turnover	0.27	0.38	0.17
Increase / (Decrease) in Invested Capital	9.23	24	-8.72
Enterprise Value (EV)	307	441	261
Market Capitalization	390	505	287
Book Value per Share	$0.54	$0.50	$0.22
Tangible Book Value per Share	$0.54	$0.41	$0.17
Total Capital	90	109	98
Total Debt	0.00	13	49
Total Long-Term Debt	0.00	13	25
Net Debt	-83	-64	-26
Capital Expenditures (CapEx)	4.36	1.94	0.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.13	-11	-14
Debt-free Net Working Capital (DFNWC)	80	66	61
Net Working Capital (NWC)	80	66	37
Net Nonoperating Expense (NNE)	15	21	37
Net Nonoperating Obligations (NNO)	-83	-64	-26
Total Depreciation and Amortization (D&A)	2.25	7.86	11
Debt-free, Cash-free Net Working Capital to Revenue	-470.93%	-148.64%	-302.30%
Debt-free Net Working Capital to Revenue	11,985.24%	912.67%	1,294.02%
Net Working Capital to Revenue	11,985.24%	912.67%	777.66%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.32)	($0.45)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	165.96M	182.80M	209.51M
Adjusted Diluted Earnings per Share	($0.32)	($0.45)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	165.96M	182.80M	209.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	175.82M	195.27M	245.00M
Normalized Net Operating Profit after Tax (NOPAT)	-38	-62	-57
Normalized NOPAT Margin	-5,681.17%	-857.37%	-1,210.32%
Pre Tax Income Margin	-7,995.63%	-1,125.44%	-2,052.98%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-855.31	-1,020.20	-20.63
NOPAT to Interest Expense	-608.44	-777.66	-13.43
EBIT Less CapEx to Interest Expense	-925.61	-1,044.39	-20.71
NOPAT Less CapEx to Interest Expense	-678.74	-801.84	-13.52
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-100.00%	0.00%	123.43%	4.78%	0.00%	0.00%	22.25%	477.51%	-81.85%	-67.65%
EBITDA Growth	-27.16%	-8.01%	-29.12%	-41.92%	-71.34%	-33.64%	-48.75%	-18.03%	34.98%	-41.67%
EBIT Growth	-27.63%	-10.89%	-43.60%	-49.52%	-80.98%	-37.06%	-38.38%	-17.29%	33.75%	-38.76%
NOPAT Growth	-30.12%	-10.89%	-61.47%	-74.85%	-82.38%	-42.12%	-26.04%	-3.06%	34.27%	7.12%
Net Income Growth	-36.98%	-6.73%	-44.49%	-51.57%	-82.62%	-46.47%	-38.29%	-16.11%	33.88%	-57.85%
EPS Growth	0.00%	0.00%	-37.50%	-50.00%	-50.00%	-25.00%	-18.18%	8.33%	41.67%	0.00%
Operating Cash Flow Growth	9.59%	-2.99%	-23.61%	-71.62%	-126.23%	-97.29%	-53.98%	-11.97%	30.89%	9.18%
Free Cash Flow Firm Growth	-4.35%	-47.85%	-91.53%	-139.47%	-192.75%	-101.68%	3.68%	60.40%	80.25%	89.01%
Invested Capital Growth	214.11%	420.36%	4,772.73%	1,195.65%	976.57%	347.63%	65.98%	-7.96%	-12.24%	-27.69%
Revenue Q/Q Growth	-100.00%	0.00%	0.00%	-57.93%	218.24%	387.20%	-81.26%	98.74%	-90.00%	768.42%
EBITDA Q/Q Growth	6.46%	-6.87%	-23.90%	-14.59%	-12.93%	16.64%	-37.28%	9.07%	37.79%	-81.63%
EBIT Q/Q Growth	5.49%	-8.90%	-34.66%	-7.87%	-14.40%	17.53%	-35.39%	8.56%	35.38%	-72.74%
NOPAT Q/Q Growth	4.15%	-6.82%	-51.42%	-12.78%	0.02%	16.77%	-34.30%	7.78%	36.23%	-17.61%
Net Income Q/Q Growth	5.49%	-4.86%	-41.20%	-8.31%	-13.88%	15.90%	-33.32%	9.06%	35.16%	-100.78%
EPS Q/Q Growth	0.00%	0.00%	-37.50%	-9.09%	0.00%	16.67%	-30.00%	15.38%	36.36%	0.00%
Operating Cash Flow Q/Q Growth	7.06%	6.76%	-60.44%	-23.44%	-22.51%	18.69%	-25.22%	10.24%	24.38%	-6.85%
Free Cash Flow Firm Q/Q Growth	15.84%	-39.71%	-58.01%	-28.89%	-2.89%	3.75%	9.39%	47.01%	48.68%	46.46%
Invested Capital Q/Q Growth	28.68%	196.83%	121.05%	53.45%	6.92%	23.42%	2.94%	-14.91%	1.95%	1.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	30.43%	-113.07%	40.31%	82.32%	-33.58%	18.21%	-206.84%	-149.45%
EBITDA Margin	0.00%	0.00%	-2,087.21%	-5,684.80%	-2,017.29%	-345.15%	-2,539.64%	-1,161.89%	-7,227.89%	-1,511.70%
Operating Margin	0.00%	0.00%	-2,709.85%	-7,264.44%	-2,282.24%	-389.90%	-2,793.93%	-1,296.37%	-8,266.32%	-1,119.52%
EBIT Margin	0.00%	0.00%	-2,409.97%	-6,179.33%	-2,221.39%	-376.04%	-2,727.93%	-1,255.05%	-8,110.00%	-1,613.15%
Profit (Net Income) Margin	0.00%	0.00%	-2,433.12%	-6,264.13%	-2,241.55%	-386.92%	-2,752.41%	-1,259.47%	-8,166.84%	-1,888.18%
Tax Burden Percent	100.00%	99.67%	100.96%	101.37%	100.91%	102.47%	100.90%	100.35%	100.70%	100.26%
Interest Burden Percent	100.00%	96.60%	100.00%	100.00%	100.00%	100.42%	100.00%	100.00%	100.00%	116.74%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-262.12%	-439.76%	-247.38%	-102.90%	-703.23%	-356.75%	-1,968.88%	-135.70%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-257.30%	-435.47%	-238.73%	-94.99%	-692.27%	-347.55%	-1,961.10%	-95.35%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	235.82%	381.31%	202.54%	75.27%	533.56%	264.29%	1,388.87%	59.58%
Return on Equity (ROE)	0.00%	0.00%	-26.30%	-58.44%	-44.83%	-27.62%	-169.66%	-92.46%	-580.02%	-76.12%
Cash Return on Invested Capital (CROIC)	-1,739.39%	-667.66%	-738.76%	-564.67%	-582.80%	-450.06%	-369.25%	-282.44%	-241.13%	-188.60%
Operating Return on Assets (OROA)	0.00%	0.00%	-21.92%	-53.67%	-39.08%	-22.32%	-163.89%	-89.66%	-589.38%	-60.41%
Return on Assets (ROA)	0.00%	0.00%	-22.13%	-54.40%	-39.43%	-22.96%	-165.36%	-89.98%	-593.51%	-70.71%
Return on Common Equity (ROCE)	0.00%	0.00%	-26.30%	-58.44%	-44.83%	-27.62%	-169.66%	-92.46%	-580.02%	-76.12%
Return on Equity Simple (ROE_SIMPLE)	-61.01%	0.00%	-68.12%	-58.63%	-77.94%	0.00%	-96.08%	-118.73%	-129.83%	0.00%
Net Operating Profit after Tax (NOPAT)	-9.17	-9.80	-15	-17	-17	-14	-19	-17	-11	-13
NOPAT Margin	0.00%	0.00%	-1,896.89%	-5,085.11%	-1,597.56%	-272.93%	-1,955.75%	-907.46%	-5,786.42%	-783.66%
Net Nonoperating Expense Percent (NNEP)	-3.54%	-3.72%	-4.82%	-4.29%	-8.64%	-7.91%	-10.96%	-9.20%	-7.78%	-40.35%
Return On Investment Capital (ROIC_SIMPLE)	-	-10.92%	-	-	-	-12.83%	-	-	-	-13.23%
Cost of Revenue to Revenue	0.00%	0.00%	69.57%	213.07%	59.69%	17.68%	133.58%	81.79%	306.84%	249.45%
SG&A Expenses to Revenue	0.00%	0.00%	1,117.26%	2,945.90%	835.05%	186.57%	949.58%	407.68%	3,473.16%	358.97%
R&D to Revenue	0.00%	0.00%	1,623.02%	4,210.03%	1,488.44%	285.83%	1,810.77%	747.58%	4,597.89%	531.15%
Operating Expenses to Revenue	0.00%	0.00%	2,740.28%	7,151.37%	2,322.54%	472.22%	2,760.36%	1,314.58%	8,059.47%	970.06%
Earnings before Interest and Taxes (EBIT)	-13	-14	-19	-20	-23	-19	-26	-24	-15	-27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-13	-16	-19	-21	-18	-24	-22	-14	-25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.98	4.35	5.42	7.19	4.19	5.28	3.83	2.78	3.68	5.88
Price to Tangible Book Value (P/TBV)	6.99	4.35	6.95	8.58	5.11	6.43	4.66	3.34	4.55	7.59
Price to Revenue (P/Rev)	489.40	587.62	428.32	727.69	190.57	69.62	48.34	24.33	29.77	61.10
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	217.10	43.73	25.63	30.18	13.27	14.01	11.29	7.39	8.89	11.46
Enterprise Value to Revenue (EV/Rev)	421.21	463.06	363.54	647.90	156.85	60.76	39.19	18.03	24.43	55.56
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.08	0.09	0.13	0.05	0.00	0.00	1.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.51
Financial Leverage	-1.00	-0.98	-0.92	-0.88	-0.85	-0.79	-0.77	-0.76	-0.71	-0.62
Leverage Ratio	1.17	1.21	1.27	1.24	1.33	1.32	1.37	1.32	1.37	1.73
Compound Leverage Factor	1.17	1.17	1.27	1.24	1.33	1.32	1.37	1.32	1.37	2.03
Debt to Total Capital	0.00%	0.00%	0.00%	7.01%	8.01%	11.72%	5.19%	0.00%	0.00%	50.10%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	7.01%	8.01%	0.00%	5.19%	0.00%	0.00%	24.81%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	11.72%	0.00%	0.00%	0.00%	25.28%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	92.99%	91.99%	88.28%	94.81%	100.00%	100.00%	49.90%
Debt to EBITDA	0.00	0.00	0.00	-0.13	-0.11	-0.17	-0.06	0.00	0.00	-0.61
Net Debt to EBITDA	1.64	0.00	0.00	1.33	0.96	0.87	0.83	0.00	0.00	0.32
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-0.17	0.00	0.00	0.00	-0.31
Debt to NOPAT	0.00	0.00	0.00	-0.17	-0.15	-0.20	-0.08	0.00	0.00	-0.82
Net Debt to NOPAT	2.26	0.00	0.00	1.75	1.25	1.03	1.03	0.00	0.00	0.43
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-0.20	0.00	0.00	0.00	-0.41
Altman Z-Score	7.00	1.40	-0.26	6.82	-1.09	0.88	-1.84	-5.77	-6.60	-7.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.82	7.97	3.48	4.55	3.80	4.23	4.64	5.26	5.00	1.79
Quick Ratio	8.36	7.24	3.08	4.17	3.27	3.64	4.18	4.64	4.09	1.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-14	-19	-30	-39	-40	-38	-29	-15	-7.87	-4.22
Operating Cash Flow to CapEx	-1,013.72%	-358.80%	-2,192.20%	-1,915.07%	-4,102.21%	0.00%	-18,209.65%	-11,225.30%	0.00%	-14,617.48%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.01	0.01	0.01	0.02	0.06	0.06	0.07	0.07	0.04
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	9.14	6.45	16.76	5.01
Inventory Turnover	0.08	0.05	0.26	0.56	0.71	0.97	1.02	1.22	1.07	2.44
Fixed Asset Turnover	0.33	0.13	0.16	0.17	0.31	0.92	0.79	1.00	0.95	0.58
Accounts Payable Turnover	0.08	0.04	0.23	0.80	1.00	1.28	1.21	2.61	2.28	4.43
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	39.95	56.57	21.77	72.87
Days Inventory Outstanding (DIO)	4,672.00	6,644.83	1,406.11	657.44	515.76	377.57	356.88	298.83	342.59	149.49
Days Payable Outstanding (DPO)	4,622.80	10,302.13	1,582.05	455.91	365.67	285.21	301.48	139.79	159.88	82.48
Cash Conversion Cycle (CCC)	49.20	-3,657.30	-175.94	201.54	150.09	92.37	95.35	215.62	204.49	139.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2.37	7.03	16	24	26	31	26	22	22	23
Invested Capital Turnover	8.33	0.27	0.14	0.09	0.15	0.38	0.36	0.39	0.34	0.17
Increase / (Decrease) in Invested Capital	4.45	9.23	15	22	23	24	10	-1.90	-3.12	-8.72
Enterprise Value (EV)	514	307	398	720	338	441	291	162	199	261
Market Capitalization	598	390	469	808	411	505	359	219	243	287
Book Value per Share	$0.52	$0.54	$0.49	$0.64	$0.52	$0.50	$0.48	$0.38	$0.31	$0.22
Tangible Book Value per Share	$0.52	$0.54	$0.38	$0.53	$0.43	$0.41	$0.40	$0.32	$0.25	$0.17
Total Capital	86	90	87	121	107	109	99	79	66	98
Total Debt	0.00	0.00	0.00	8.48	8.55	13	5.14	0.00	0.00	49
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	13	0.00	0.00	0.00	25
Net Debt	-83	-83	-71	-89	-73	-64	-68	-57	-43	-26
Capital Expenditures (CapEx)	0.89	2.34	0.62	0.87	0.50	-0.05	0.11	0.17	-0.01	0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.37	-3.13	-16	-8.08	-5.39	-11	-3.45	-2.83	-1.04	-14
Debt-free Net Working Capital (DFNWC)	78	80	55	89	76	66	70	54	42	61
Net Working Capital (NWC)	78	80	55	81	67	66	65	54	42	37
Net Nonoperating Expense (NNE)	3.68	3.68	4.19	3.88	6.74	5.81	7.62	6.69	4.52	18
Net Nonoperating Obligations (NNO)	-83	-83	-71	-89	-73	-64	-68	-57	-43	-26
Total Depreciation and Amortization (D&A)	0.52	0.82	2.52	1.63	2.14	1.58	1.80	1.77	1.68	1.67
Debt-free, Cash-free Net Working Capital to Revenue	-439.56%	-470.93%	-1,474.36%	-726.82%	-249.91%	-148.64%	-46.47%	-31.45%	-12.72%	-302.30%
Debt-free Net Working Capital to Revenue	6,379.28%	11,985.24%	5,003.19%	8,016.29%	3,517.75%	912.67%	937.51%	598.88%	520.88%	1,294.02%
Net Working Capital to Revenue	6,379.28%	11,985.24%	5,003.19%	7,252.66%	3,121.46%	912.67%	868.41%	598.88%	520.88%	777.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.08)	($0.11)	($0.12)	($0.12)	($0.10)	($0.13)	($0.11)	($0.07)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	166.04M	165.96M	174.70M	177.30M	188.31M	182.80M	196.75M	208.67M	213.00M	209.51M
Adjusted Diluted Earnings per Share	$0.00	($0.08)	($0.11)	($0.12)	($0.12)	($0.10)	($0.13)	($0.11)	($0.07)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	166.04M	165.96M	174.70M	177.30M	188.31M	182.80M	196.75M	208.67M	213.00M	209.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	166.04M	175.82M	176.52M	187.78M	189.99M	195.27M	206.66M	212.75M	219.02M	245.00M
Normalized Net Operating Profit after Tax (NOPAT)	-9.17	-9.80	-15	-17	-17	-14	-19	-15	-11	-13
Normalized NOPAT Margin	0.00%	0.00%	-1,896.89%	-5,088.30%	-1,598.23%	-272.93%	-1,955.75%	-795.94%	-5,794.53%	-783.66%
Pre Tax Income Margin	0.00%	0.00%	-2,409.97%	-6,179.33%	-2,221.39%	-377.61%	-2,727.93%	-1,255.05%	-8,110.00%	-1,883.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About MicroVision's Financials

When does MicroVision's financial year end?

According to the most recent income statement we have on file, MicroVision's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MicroVision's net income changed over the last 2 years?

MicroVision's net income appears to be on an upward trend, with a most recent value of -$96.92 million in 2024, rising from -$53.09 million in 2022. The previous period was -$82.84 million in 2023. See where experts think MicroVision is headed by visiting MicroVision's forecast page.

What is MicroVision's operating income?

MicroVision's total operating income in 2024 was -$85.52 million, based on the following breakdown:

Total Gross Profit: -$2.83 million
Total Operating Expenses: $82.69 million

How has MicroVision revenue changed over the last 2 years?

Over the last 2 years, MicroVision's total revenue changed from $664 thousand in 2022 to $4.70 million in 2024, a change of 607.2%.

How much debt does MicroVision have?

MicroVision's total liabilities were at $72.39 million at the end of 2024, a 114.0% increase from 2023, and a 186.6% increase since 2022.

How much cash does MicroVision have?

In the past 2 years, MicroVision's cash and equivalents has ranged from $20.54 million in 2022 to $54.49 million in 2024, and is currently $54.49 million as of their latest financial filing in 2024.

How has MicroVision's book value per share changed over the last 2 years?

Over the last 2 years, MicroVision's book value per share changed from 0.54 in 2022 to 0.22 in 2024, a change of -58.8%.

Related Companies

This page (NASDAQ:MVIS) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MicroVision (MVIS) Financials

Frequently Asked Questions About MicroVision's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MicroVision (MVIS) Financials

Annual Income Statements for MicroVision

Quarterly Income Statements for MicroVision

Annual Cash Flow Statements for MicroVision

Quarterly Cash Flow Statements for MicroVision

Annual Balance Sheets for MicroVision

Quarterly Balance Sheets for MicroVision

Annual Metrics and Ratios for MicroVision

Quarterly Metrics and Ratios for MicroVision

Frequently Asked Questions About MicroVision's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools